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Abstract  Cardiovascular  disease  (CVD)  is  the  leading  cause  of  death  in  developed  countries
and  disproportionately  affects  older  adults.  Frailty  is  a  complex  clinical  syndrome  with  multiple
causes  and  contributing  factors  in  which  there  is  increased  vulnerability  when  exposed  to  a
minor  stressor  and  increased  risk  for  adverse  outcomes,  such  as  disability,  hospitalization  and
mortality.  Frailty  is  an  important  prognostic  factor  in  patients  with  CVD,  and  so  identifying  this
feature  when  assessing  these  patients  may  help  to  individually  tailor  cardiovascular  treatment.
The  first  step  is  to  identify  frailty.  Several  tools  have  been  validated  as  screening  methods  for
frailty.  However,  they  diverge  with  regard  to  complexity,  nature,  feasibility  and  the  outcome
they  can  predict.  The  aim  of  this  review  is  to  describe  the  available  screening  tools  for  frailty
and  to  examine  their  usefulness  in  patients  with  CVD.
©  2019  Sociedade  Portuguesa  de  Cardiologia.  Published  by  Elsevier  Espan˜a,  S.L.U.  
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Fragilidade  nas  doenc¸as  cardiovasculares:  instrumentos  de  rastreio
Resumo  As  doenc¸as  cardiovasculares  (DCV)  constituem  a  principal  causa  de  morte  nos  países
desenvolvidos  e  afetam  desproporcionalmente  os  indivíduos  idosos.  A  fragilidade  é  definida
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como  uma  síndrome  clínica  complexa  com  múltiplos  fatores  predisponentes  e  caraterizada  por
um  aumento  da  vulnerabilidade  e  maior  risco  de  desfechos  adversos,  nomeadamente,  inca-
pacidade,  institucionalizac¸ão  e/ou  mortalidade.  Parece  ser  um  fator  prognóstico  importante
em  doentes  com  DCV,  pelo  que  o  reconhecimento  dos  doentes  com  fragilidade  pode  permitir
identificar  os  doentes  com  maior  risco  e  assim  orientar  a  estratégia  terapêutica  cardiovascular
,  primeiramente  é  fundamental  identificar  a  fragilidade.  Váriosmais  segura  e  eficaz.  Assim∗ Corresponding author.
E-mail address: anazaomfr@gmail.com (A. Zão).
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0870-2551/© 2019 Sociedade Portuguesa de Cardiologia. Published by Elsevier Espan˜a, S.L.U. 
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instrumentos  foram  validados  como  métodos  de  rastreio  de  fragilidade.  No  entanto,  eles
divergem  quanto  à  complexidade,  natureza,  viabilidade  e  resultados  que  podem  prever.  O  obje-
tivo  desta  revisão  é  descrever  as  ferramentas  disponíveis  para  rastreio  de  fragilidade  e  avaliar
as  suas  diferenc¸as  e  utilidade  nos  doentes  com  DCV.
©  2019  Sociedade  Portuguesa  de  Cardiologia.  Publicado  por  Elsevier  Espan˜a,  S.L.U.  Este  é  um
artigo  Open  Access  sob  a  licença  de  CC  BY-NC-SA  (http://creativecommons.org/licenses/by-nc-
sa/4.0/).
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ACS acute  coronary  syndrome
BADL basic  activities  of  daily  living
CABG coronary  artery  bypass  grafting
CAF Comprehensive  Assessment  of  Frailty
CFS Clinical  Frailty  Scale
CHS Cardiovascular  Health  Study
CSHA Canadian  Study  of  Health  and  Aging
CVD cardiovascular  disease
EFS Edmonton  Frail  Scale
EFT Essential  Frailty  Toolset
EuroSCORE European  System  for  Cardiac  Operative
Risk  Evaluation
GFI  Groningen  Frailty  Indicator
GFST Gérontopôle  Frailty  Screening  Tool
LVAD left  ventricular  assist  device
MACCE major  adverse  cardiovascular  and  cerebrovas-
cular  events
MMSE  Mini-Mental  State  Exam
MNA Mini  Nutritional  Assessment
MPI Multidimensional  Prognostic  Instrument
MSSA MacArthur  Study  of  Successful  Aging
STS Society  of  Thoracic  Surgeons
TAVI transcatheter aortic  valve  implantation
TFI Tilburg  Frailty  Indicator
TUG Timed  Up  and  Go
ntroduction
ardiovascular  disease  (CVD)  is  the  leading  cause  of  death
n developed  countries  and  disproportionately  affects  older
dults.1 Age  by  itself  is  a  strong  predictor  of  adverse
vents in  acute  coronary  syndrome  (ACS)  and  other  CVD.
ost prognostic  models  consider  age,  but  do  not  take  into
ccount other  related  factors,  such  as  frailty,  health  status,
isability and  cognition.2 Patients  who  have  lower  physio-
ogical reserve  and  functional  capacity  are  at  higher  risk
or homeostatic  disruption  when  facing  a  stressful  event.3
dentification  of  patients  at  increased  risk  of  frailty  and  a
etter understanding  of  the  impact  of  this  variable  on  CVD
utcomes may  improve  the  quality  of  healthcare.
The  aim  of  this  review  is  to  define  frailty  and  to  describe
he available  screening  tools  that  can  help  to  identify  frailty
F
t
cmong  patients  with  CVD.  We  discuss  the  advantages  and
imitations of  each  tool,  as  well  as  the  potential  impact  of
heir use  in  clinical  practice.
railty
efinition  and  epidemiology
railty  is  a  complex  clinical  syndrome  with  multiple  causes
nd contributing  factors  in  which  there  is  increased  vul-
erability when  exposed  to  a  minor  stressor  and  increased
isk for  adverse  outcomes,  such  as  disability,  hospitalization
nd/or mortality.4,5 This  is  often  manifested  by  maladaptive
esponse to  stressors,  leading  to  a vicious  cycle  toward  func-
ional decline  and  other  serious  adverse  health  outcomes.
t is  characterized  by  diminished  strength,  endurance  and
hysiological reserve  across  the  neuromuscular,  metabolic
nd immune  systems.6 It  is  important  to  note  that  old  age
tself does  not  define  frailty,  because  some  patients  remain
igorous despite  advanced  age,  while  others  can  have  func-
ional decline  in  the  absent  of  apparent  stress  factors  or
ailure to  rebound  following  hospitalization  or  illness.5 Thus,
t is  important  to  note  the  difference  between  biological  age
nd  chronological  age.7
The  prevalence  of  frailty  ranges  from  4%  to  17%,  and  is
igher among  women  (almost  double  that  in  men),  increas-
ng significantly  in  patients  older  than  80  years  of  age.8,9
re-frailty  (which  describes  patients  at  risk  for  frailty  who
ulfill some,  but  not  all,  criteria  for  frailty)  has  been  also
een the  subject  of  various  studies,  which  show  a  prevalence
round 28-44%.9 Several  factors  are  thought  to  contribute
o the  development  of  frailty,  including  poor  nutrition,
educed exercise  tolerance,  aging,  chronic  inflammation
nd immunological  decline.7 Thus,  it  can  potentially  be
revented or  treated  with  specific  modalities,  such  as  exer-
ise, protein-calorie  and  vitamin  D  supplementation,  and
eduction of  polypharmacy.6 However,  a common  feature  of
rail persons  is  mild  cognitive  impairment,  which  hampers
he application  of  therapeutic  regimens,  especially  exercise
rograms.
athophysiologyrailty  is  a  multifactorial  condition.  The  literature  shows
hat certain  changes  in  physiological  systems  are  asso-
iated with  an  increased  risk  for  frailty,  including  a
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proinflammatory  state  and  elevated  markers  of  blood
clotting,10 sarcopenia,7 anemia,11 anabolic  hormone
deficiencies,12,13 insulin  resistance,14 significant  immune
system alterations,15 and  oxidative  stress.16
The  importance  of  diagnosing  frailty  in  patients
with cardiovascular  disease
The  aging  of  populations  is  increasing  the  number  of  frail
patients with  CVD.  Thus,  identifying  frailty  has  important
implications for  clinical  care.  Frailty  worsens  prognosis  in
patients with  CVD  (Table  1)  and  of  patients  undergoing  car-
diac surgery  and  other  cardiovascular  interventions,  and
can reduce  the  net  benefits  of  some  cardiac  interventions
because of  competing  risks.17,18 Frailty  also  increases  the
risk of  cardiovascular  and  non-cardiovascular  mortality  and
the need  for  rehabilitation  and  institutional  care.2,19,20 In
the large  TRILOGY  ACS  trial,  which  included  4671  patients
older than  65  years  with  ACS,  25%  were  considered  pre-frail
and 5%  frail  (according  to  the  Fried  score).21 Frail  patients
were more  likely  to  suffer  stroke  or  cardiovascular  death
after adjusting  for  the  Global  Registry  of  Acute  Coronary
Events (GRACE)  score.  Frailty  is  also  a  strong  independent
predictor of  mortality  in  heart  failure  patients.  One  study
found a  population-attributable  risk  associated  with  frailty
for emergency  department  visits  of  35%  and  for  hospital-
izations of  19%  among  patients  with  heart  failure.22 Kang
et al.  found  that  frailty  was  strongly  and  independently  asso-
ciated with  short-term  outcomes  for  elderly  patients  with
ACS.23 In  a  study  by  Ekerstad  et  al.  frailty  was  strongly  and
independently associated  with  in-hospital  mortality,  one-
month mortality,  prolonged  hospital  care,  and  the  primary
composite outcome  in  patients  with  non-ST-segment  eleva-
tion myocardial  infarction.24 Ricci  et  al.  also  found  that  frail
and pre-frail  older  individuals  accounted  for  a  substantial
proportion of  those  with  more  cardiovascular  risk  factors,
especially diabetes,  highlighting  the  need  for  preventive
strategies in  order  to  avoid  the  co-occurrence  of  CVD  and
frailty.25
Similarly,  frailty  is  associated  with  higher  mortality  and
morbidity and  greater  need  for  health  care  in  patients  with
valvular disease  undergoing  cardiac  surgery.20,26
The  number  of  elderly  patients  undergoing  cardiac
surgery is  increasing.  Frailty  screening  may  be  useful  to
identify patients  with  increased  risk  of  adverse  outcomes.
Sundermann et  al.  found  that  patients  who  died  within  one
year had  a  median  Comprehensive  Assessment  of  Frailty
(CAF) score  of  16  [5;33]  compared  to  11  [3;33]  in  one-year
survivors (p=0.001),  proving  the  prognostic  value  of  frailty
in cardiac  surgery.20 Afilalo  et  al.  also  demonstrated  the
association between  frailty  and  mortality  or  major  mor-
bidity after  coronary  artery  bypass  grafting  (CABG)  and/or
valve surgery  (odds  ratio  [OR]  2.63;  95%  confidence  inter-
val [CI]  1.17-5.90).28 In  a  study  by  Jung  et  al.,  frailty  was
associated with  a  3-  to  8-fold  increase  in  risk  of  postoper-
ative delirium.  According  to  these  authors,  ‘frail’  and  ‘fit’
may be  considered  two  ends  of  a  continuum,  and  the  risk
of postoperative  delirium  grows  as  one  becomes  increas-
ingly frail.29 There  has  also  been  interest  in  understanding
whether preoperative  frailty  is  associated  with  worse  out-
comes after  implantation  of  a  left  ventricular  assist  device
a
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LVAD)  as  destination  therapy.  A  study  by  Dunlay  et  al.  using
 deficit  index  to  assess  frailty  found  that  patients  who  were
ntermediate frail  (adjusted  HR  1.70,  95%  CI  0.71-4.31)  and
rail (HR  3.08,  95%  CI  1.40-7.48)  were  at  increased  risk  for
eath (p=0.004  for  trend).  The  mean  number  of  days  alive
ut of  hospital  the  first  year  after  LVAD  implantation  was
igher for  patients  who  were  not  frail.30 Schoenenberger
t al.  studied  elderly  patients  undergoing  transcatheter
ortic valve  implantation  (TAVI)  and  showed  that  all  the
omponents of  their  geriatric  baseline  examination  helped
redict functional  decline  after  intervention  (OR:  3.31;  95%
I 1.21-9.03).26 Stortecky  et  al.  found  that  frailty  was  asso-
iated with  increased  all-cause  mortality  (OR:  3.68;  95%  CI
.21-11.19), and  with  increased  major  adverse  cardiovas-
ular and  cerebrovascular  events  (MACCE)  (OR:  4.89;  95%
I 1.64-14.60)  one  year  after  TAVI  (OR:  3.68;  95%  CI  1.21-
1.19).31
Pre-frailty,  which  is  a potentially  reversible  state,  also
ppears to  have  some  prognostic  value.  The  findings  of  Sergi
t al.  suggest  that  pre-frailty  is  independently  associated
ith a higher  risk  of  older  adults  developing  CVD.  Among
he physical  domains  of  pre-frailty,  low  gait  speed  seems  to
e the  best  predictor  of  future  CVD.32
Assessment  of  frailty  may  lead  to  patients  being  reclas-
ified to  different  clinical  risk  categories,  suggesting  it
ignals risk  not  captured  by  currently  used  risk  assessment
cores.2,32
ow  to  screen  for  frailty
n  ideal  frailty  screening  tool  should  (1)  be  able  to  accu-
ately identify  frailty;  (2)  predict  the  response  of  frail
atients to  potential  therapies;  and  (3)  be  simple  and  easy
o apply  and  have  low  cost.33 Simple  and  rapid  screen-
ng tests  have  been  developed  and  validated  to  enable  the
bjective recognition  of  frail  persons.  They  differ  mainly
n the  nature  and  number  of  deficits  they  measure,  in  line
ith two  contrasting  conceptual  models:  the  frailty  phe-
otype, or  physical  frailty,  and  the  frailty  index  or  deficit
ccumulation.34 The  phenotype  concept  considers  frailty  as
 syndrome,  consisting  of  a  small  number  of  highly  spe-
ific deficits  in  health,  such  as  unintentional  weight  loss,
xhaustion, slowness,  low  physical  activity  and  impaired  grip
trength. Further  specific  health  deficits,  such  as  cognitive
eficits, have  been  proposed  as  part  of  a  frailty  phenotype
cale. By  contrast,  frailty  indices  are  based  on  the  concept  of
umulative deficit,  assessing  frailty  through  a  larger  number
f unspecified  age-associated  health  deficits  (usually  at  least
0). The  most  commonly  used  are  the  FRAIL  Questionnaire
creening tool,35--38 the  Cardiovascular  Health  Study  Frailty
creening Scale  (Fried  criteria),9 the  Clinical  Frailty  Scale
CFS),39 frailty  indices,40,41 and  the  Edmonton  Frail  Scale42
Table  2).
he  FRAIL  Questionnaire  screening  tool
he  FRAIL  Questionnaire  screening  tool  considers  deficits
ccumulated in  five  domains,  forming  its  acronym:  Fatigue
self-reported), Resistance,  Ambulation  (slow  walking
peed), Illnesses,  and  Loss  of  weight  (5%  or  more  in  the  past
ear). The  five  domains  are  weighted  equally.  Individuals
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Table  1  Studies  of  frailty  in  cardiovascular  disease.
Study  CVD  and
population
Screening  tools  for
frailty
Other tools  Results
Kang  et  al.23 ACS
352  patients,
age >65  years
CFS  CGA
CAD-specific  index
CFS  was  useful  in  evaluation  of  elderly
patients  with  ACS.  Frailty  was  strongly  and
independently  associated  with  short-term
outcomes  for  elderly  patients  with  ACS.
Uchmanowicz
et  al.50
ACS  TFI  CGA  Significant  correlations  were  demonstrated
between  the  values  of  the  TFI  and  other
scales.
Ekerstad  et  al.24 ACS
307  patients,
age >75  years
CFS  CAD-specific  index Frailty  was  strongly  and  independently
associated with  in-hospital  mortality,
1-month  mortality,  prolonged  hospital  care
and  the  primary  composite  outcome.  The
combined  use  of  frailty  and  comorbidity
may  constitute  a  novel  risk  prediction
concept  in  regard  to  cardiovascular
patients with  complex  needs.
Boxer et  al.17 Heart  failure  CHS  6  MW  Both  tools  were  associated  with  mortality
(p=0.005)  and  highly  correlated.  The  6  MW
may  be  useful  as  a  measure  of  frailty.
Invasive cardiac  interventions
Afilalo et  al.51 TAVI  and  valve
surgery
1020 patients,
median  age  82
years
EFT
CHS
Fried+a
CFS
PPB
Bern  Scale
Columbia  Scale
Frailty is  a  risk  factor  for  death  and
disability  following  TAVI  and  valve  surgery.
The  EFT  outperformed  other  frailty  scales
and  is  recommended  for  use  in  this  setting.
Jung  et  al.29 Elective
cardiac  surgery,
133  patients
MFC
35-item  Frailty
Index
SPPB
SPBB
EuroSCORE  II
Frailty  results  in  a  3-  to  8-fold  increase  in
risk  of  postoperative  delirium,  independent
of  the  EuroSCORE  II.  The  addition  of  frailty
improves  the  ability  of  the  EuroSCORE  II  to
predict  postoperative  delirium,  pointing  to
opportunities  for  improved  prevention  and
management.
Dunlay  et  al.30 LVAD  31-item  Frailty
Index
- Frailty  before  destination  LVAD
implantation  is  associated  with  increased
risk  of  death  and  may  represent  a
significant  patient  selection  consideration.
Schoenenberger
et  al.26
TAVI  Geriatric  baseline
examination
EuroSCORE
STS
The geriatric  baseline  examination,  but  not
established  risk  scores,  was  predictive
of  functional  decline.
Green et  al.53 TAVI  MFC  Frailty  was  associated  with  increased
1-year mortality  after  TAVI.
Stortecky et  al.31 TAVI  MGA  EuroSCORE
STS
MACCE
Risk prediction  can  be  improved  by  adding
multidimensional  geriatric
assessment-based information  to  global  risk
scores.
Afilalo  et  al.28 CABG  and/or
valve surgery
Simplified  Fried
criteria (5-item)
Fried criteria
(7-item)
MSSA
Five-meter  gait
speed test
Disability  scalesb
Surgical  risk  scoresc
Clinicians  should  use  an  integrative
approach combining  frailty,  disability,  and
risk  scores  to  better  characterize  elderly
patients  referred  for  cardiac  surgery  and
identify  those  that  are  at  increased  risk.
Frailty  in  cardiovascular  disease  147
Table  1  (Continued)
Study  CVD  and
population
Screening  tools  for
frailty
Other tools  Results
Sundermann
et  al.20
CABG  (25%)  vs.
valve surgery
(35%) vs.
combined
procedures
(26%)
CAF  EuroSCORE
STS
CAF is  an  additional  tool  to  assess  prognosis
of  elderly  patients  before  cardiac  surgical
interventions.  The  CAF  score  facilitates
prediction  of  30-day  outcome  of  high-risk
elderly  patients.
6 MW: six-minute walk test; ACS: acute coronary syndrome; CABG: coronary artery bypass grafting; CAD: coronary artery disease; CAF:
Comprehensive Assessment of Frailty score; CFS: Clinical Frailty Scale; CGA: Comprehensive Geriatric Assessment; CHS: Cardiovascular
Health Study scale; CVD: cardiovascular disease; EFT: Essential Frailty Toolset; EuroSCORE: European System for Cardiac Operative
Risk Evaluation; LVAD: left ventricular assist device; MACCE: major adverse cardiovascular and cerebral events; MFC: Modified Fried
Criteria; MSSA: 4-item MacArthur Study of Successful Aging frailty scale; MGA: Multidimensional Geriatric Assessment; PPB: Physical
Performance Battery; SPPB: Short Physical Performance Battery; STS: Society of Thoracic Surgeons risk score; TAVI: Transcatheter aortic
valve implantation; TFI: Tilburg Frailty Indicator.
a Fried+: Fried criteria+cognition and mood assessment.
b Disability scales: 6-item Katz Activities of Daily Living scale; 7-item Older Americans Research and Services Instrumental Activities of
Daily Living scale; 7-item Nagi scale.
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Mortality or Major Morbidity; EuroSCORE; revised Parsonnet score
with  two  deficits  are  considered  pre-frail,  and  those  with
three or  more  deficits  are  classified  as  frail.
Fried  criteria  for  frailty
The  Fried  criteria  for  frailty  (also  known  as  the  Cardiovascu-
lar Health  Study  Frailty  Screening  Scale,  the  Physical  Frailty
Phenotype and  the  Hopkins  Frailty  Phenotype)  was  first
developed in  the  Cardiovascular  Health  Study.9 It  assesses
physical characteristics  or  phenotype,  which  include  five
domains: unintentional  weight  loss  (4.5  kg  or  more  in  the
last year),  exhaustion  (self-reported),  low  physical  activity,
weakness (low  grip  strength),  and  walking  speed.9,43 Low
physical activity  is  assessed  through  the  frequency  of  mod-
erate intensity  activities,  such  as  gardening  or  household
chores. Similarly  to  the  previous  scale,  individuals  with  two
deficits are  considered  pre-frail,  and  those  with  three  or
more deficits  are  classified  as  frail.29
Clinical  Frailty  Scale
The  CFS  is  a  global  clinical  assessment  of  frailty  based  on
physical function  and  level  of  independence  with  activities
of daily  living  proposed  by  Rockwood  et  al.39 Each  point  on  its
scale has  a  visual  chart  and  a  written  description  of  frailty  to
assist the  classification  process.  Scoring  is  based  on  clinical
judgment and  ranges  from  1  (very  fit)  to  9  (terminally  ill).39
Frailty  indices
Frailty  indices  are  based  on  the  deficit  accumulation
approach to  measuring  frailty,  and  are  commonly  used  tools
to assess  frailty  in  order  to  estimate  the  related  risk  for
adverse health  outcomes,  such  as  mortality.44 A  frailty  index
is based  on  the  concept  that  frailty  is  a  consequence  of
interacting physical,  psychological,  and  social  factors.  As
deficits accumulate,  people  become  increasingly  vulnerable
u
v
ak of Mortality, the Society of Thoracic Surgeons Predicted Risk of
-Creatinine-Ejection Fraction score.
o  adverse  outcomes.  The  subject  answers  20  or  more  ques-
ions related  to  medical  and  functional  issues.  The  tool  can
e  adapted  to  information  available  in  the  medical  record
nd does  not  require  a  patient  interview  or  exam  to  assess
railty. The  70  items  of  the  original  version  are  not  to  be
onsidered a  fixed  set  of  variables  (Table  3).  It  has  been
eported that  estimates  of  risk  are  stronger  when  a  mini-
um of  50  items  are  considered,  but  shorter  versions  (as
ew as  20  items)  have  also  been  studied.39--41 Rockwood
nd Mitnitski44 proposed  a  deficit  accumulation-based  frailty
ndex using  a  comprehensive  geriatric  assessment  (FI-CGA).
his involves  the  accumulation  of  30  or  more  comorbidities,
ymptoms, diseases,  disabilities  and  other  health  deficits
nd is  expressed  as  a  ratio  calculated  as  the  number  of
eficits in  an  individual  divided  by  the  number  of  total
eficits measured;  the  greater  the  number  of  deficits,  the
igher the  score.  The  comprehensive  geriatric  assessment
CGA) includes  medical,  nutritional,  functional  and  psycho-
ogical assessments  by  a  multidimensional  team.  The  FI-CGA
as initially  developed  as  a  ten-domain  index  with  14  CGA
omponents and  was  later  expanded  to  include  52  CGA
omponents.33
dmonton  Frail  Scale
he  Edmonton  Frail  Scale  (EFS)  was  developed  to  be  practi-
al and  usable  in  the  community  setting  or  at  the  bedside.
t is  scored  out  of  17  and  contains  the  following  com-
onents: cognition,  general  health  status,  self-reported
ealth, functional  independence,  social  support,  nutrition,
ood, continence,  and  functional  performance.  The  com-sed to  classify  frailty  severity:  not  frail  (0-5),  apparently
ulnerable (6-7),  mildly  frail  (8-9),  moderately  frail  (10-11)
nd severely  frail  (12-17).
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Table  2  Characteristics  of  the  most  commonly  used  frailty  scales.
Screening  tool  Measurement  method  Criteria  for  frailty
Simple  FRAIL
Questionnaire
1.  Fatigue:  are  you  fatigued? Frail:  ≥3
Pre-frail:  1  or  22. Resistance:  cannot  walk  up  1  flight  of  stairs?
3.  Aerobic:  cannot  walk  1  block?
4.  Illnesses:  do  you  have  more  than  5  illnesses?
5.  Loss  of  weight:  Have  you  lost  more  than  5%  of  your  weight  in  the  past
6 months?
Cardiovascular
Health Study
Frailty Screening
Scale
1.  Weight  loss  --  loss  of  10  pounds  unintentionally  in  past  year  or  weight  at  age
60-weight  at  exam  ≥10%  of  age  60  weight.
Frail:  ≥3
Pre-frail:  1  or  2
2. Exhaustion  -- self-report  of  fatigue  or  felt  unusually  tired  or  weak  in  the
past month.
3. Low  activity  -- frequency  and  duration  of  physical  activities  (walking,  doing
strenuous household  chores,  doing  strenuous  outdoor  chores,  dancing,
bowling, exercise).
- Men:  <383  kcal/week=1
- Women:  <270  kcal/week=1
4. Slowness:
- Men:  walking  4  m  ≥7  s  if  height  ≤173  cm  or  ≥6  s  if  height  ≥173  cm=1
- Women:  walking  4  m  ≥7  s  if  height  ≤159  cm  or  ≥6  s  if  height  ≥159  cm=1
5. Weakness  --  grip  strength  (kg)  for  body  mass  index  (kg/m2)a
Clinical  Frailty
Scale
1.  Very  fit  --  people  who  are  robust,  active,  energetic  and  motivated.  These
people commonly  exercise  regularly.  They  are  among  the  fittest  for  their  age.
2. Well  --  people  who  have  no  active  disease  symptoms  but  are  less  fit  than
category 1.  Often,  they  exercise  or  are  very  active  occasionally,  e.g.
seasonally.
3. Managing  well  --  people  whose  medical  problems  are  well  controlled,  but
are not  regularly  active  beyond  routine  walking.
4.  Vulnerable  -- while  not  dependent  on  others  for  daily  help,  often  symptoms
limit activities.  A  common  complaint  is  being  ‘‘slowed  up’’,  and/or  being
tired during  the  day.
5. Mildly  frail  --  these  people  often  have  more  evident  slowing,  and  need  help
in high  order  IADLs  (finances,  transportation,  heavy  housework,  medications).
Typically, mild  frailty  progressively  impairs  shopping  and  walking  outside
alone, meal  preparation  and  housework.
6.  Moderately  frail  --  people  need  help  with  all  outside  activities  and  with
keeping house.  Inside,  they  often  have  problems  with  stairs  and  need  help
with bathing  and  might  need  minimal  assistance  (cuing,  standby)  with
dressing.
7. Severely  frail  --  completely  dependent  for  personal  care,  from  whatever
cause (physical  or  cognitive).  Even  so,  they  seem  stable  and  not  at  high  risk
of dying  (within  ∼6  months).
8. Very  severely  frail  --  completely  dependent,  approaching  the  end  of  life.
Typically, they  could  not  recover  even  from  a  minor  illness.
9. Terminally  ill  -  approaching  the  end  of  life.  This  category  applies  to  people
with a  life  expectancy  <6  months,  who  are  not  otherwise  evidently  frail.
Scoring frailty  in  people  with  dementia:
-  The  degree  of  frailty  corresponds  to  the  degree  of  dementia.
- Common  symptoms  in  mild  dementia  include  forgetting  the  details  of  a
recent event,  though  still  remembering  the  event  itself,  repeating  the  same
question/story and  social  withdrawal.
- In  moderate  dementia,  recent  memory  is  very  impaired,  even  though  they
seemingly can  remember  their  past  life  events  well.  They  can  do  personal
care with  prompting.
- In  severe  dementia,  they  cannot  do  personal  care  without  help.
Edmonton Frail
Scale
Cognition
Please  imagine  that  this  pre-drawn  circle  is  a  clock.  I  would  like  you  to  place
the numbers  in  the  correct  positions  then  place  the  hands  to  indicate  a  time
of ‘ten  after  eleven’
No errors=0;  Minor  spacing  errors=1;  Other  errors=2
0-5=Not  frail
6-7=Vulnerable
8-9=Mild  frailty
10-11=Moderate  frailty
12-17=Severe frailty
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Table  2  (Continued)
Screening  tool  Measurement  method  Criteria  for  frailty
General  health  status
- In  the  past  year,  how  many  times  have  you  been  admitted  to  a  hospital?
- 0  times=0;  1-2  times=1;  >2  times=2-  In  general,  how  would  you  describe  your
health? Excellent,  very  good,  good=0;  Fair=1;  Poor=2
Functional  independence
With how  many  of  the  following  activities  do  you  require  help?  (meal
preparation,  shopping,  transportation,  telephone,  housekeeping,  laundry,
managing money,  taking  medications)
0-1 activities=0;  2-4  activities=1;  5-8  activities=2
Social  support
When you  need  help,  can  you  count  on  someone  who  is  willing  and  able
to meet  your  needs?
Always=0; Sometimes=1;  Never=2
Medication  use
- Do  you  use  five  or  more  different  prescriptions  on  a  regular  basis?
No=0; Yes=1
- At  times  do  you  forget  to  take  your  prescription
medication?
No=0;  Yes=1
Nutrition
Have you  recently  lost  weight  such  that  your  clothing  has  become  looser?
No=0; Yes=1
Mood
Do you  often  feel  sad  or  depressed?
No=0; Yes=1
Continence
Do you  have  a  problem  with  losing  control  of  urine  when  you  don’t  want  to?
No=0; Yes=1
Functional  performance
I would  like  you  to  sit  in  this  chair  with  your  back  and  arms  resting.  Then,  when
I say  ‘GO,’  please  stand  up  and  walk  at  a  safe  and  comfortable  pace  to  the
mark on  the  floor  (approximately  3  m  away),  return  to  the  chair  and  sit  down
0-10 s=0;  11-20  s=1;  >20  s  or  patient  unwilling,  or  requires  assistance=2
IADLs: instrumental activities of daily living.
a Men: Body mass index (BMI) ≤24 and grip strength ≤29 kg=1; BMI 24.1-26 and grip strength ≤30 kg=1; BMI 26.1-28 kg and grip strength
rip st
1 kg=
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S≤30 kg=1; BMI >28 and strength ≤32 kg=1; women: BMI ≤23 and g
26.1-29 and grip strength ≤18 kg=1; BMI >29 and grip strength ≤2
Other  screening  tools
The  scales  described  above  are  those  most  commonly  used
to assess  frailty.  However,  other  frailty  scales  are  available,
as listed  below.
The Groningen  Frailty  Indicator  (GFI)  considers  15
dichotomous self-reported  deficits  in  four  domains:  physi-
cal, cognitive,  social,  and  psychological.45
The  Tilburg  Frailty  Indicator  contains  15  self-reported
items in  physical,  psychological,  and  social  domains.46
The  Gérontopôle  Frailty  Screening  Tool  (GFST)  comprises
two steps:  an  initial  questionnaire  (containing  six  compo-
nents: living  alone,  involuntary  weight  loss,  fatigability,
mobility, memory  complaints  and  slow  gait  speed)  followed
by the  clinician’s  judgment  of  frailty  status.47PRISMA-7  contains  seven  self-reported  components:  older
than 85  years;  male;  health  problems  which  limit  activi-
ties; health  problems  requiring  staying  at  home;  support  of
another person  needed;  social  support;  and  use  of  a  cane
s
d
mrength ≤17 kg=1; BMI 23.1-26 and grip strength ≤17.3 kg=1; BMI
1.
r  walker  or  wheelchair.  Frailty  is  defined  by  a  score  of  3  or
ore.48
The  Multidimensional  Prognostic  Instrument  (MPI)  is  a
ultidimensional prognostic  tool  used  for  hospitalized  older
atients. It  includes  eight  CGA  components:  ADL,  instru-
ental ADL,  risk  of  developing  pressure  sores,  comorbidity,
edication number,  nutritional  status,  cognitive  status,  and
iving status.49
railty  assessment  tools  used  in  cardiovascular
isease
ome  frailty  assessment  tools  have  been  designed  to  be  used
pecifically in  the  setting  of  CVD  (Table  4).  Some  of  the  tools
escribed above  are  also  used  for  this  purpose.23,24,50
Kang  et  al.  used  the  CFS,  which  was  useful  in  assess-
ent of  elderly  patients  with  ACS,  predicting  all-cause
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Table  3  List  of  variables  used  by  the  Canadian  Study  of  Health  and  Aging  (CSHA)  to  construct  the  70-item  CSHA  Frailty  Index.39
Changes in everyday activities Problems going out alone Poor limb coordination
Head  and neck problems Impaired mobility Poor coordination, trunk
Facial  bradykinesia Musculoskeletal problems Poor standing posture
Poor  muscle tone in neck Bradykinesia of the limbs Irregular gait pattern
Problems  getting dressed Poor muscle tone in limbs Falls
Problems with bathing Impaired vibration Mood problems
Problems carrying out personal grooming Tremor at rest Feeling sad, blue, depressed
Urinary  incontinence Postural tremor History of depressed mood
Toileting  problems Intention tremor Tiredness all the time
Bulk  difficulties History of Parkinson’s disease Depression (clinical impression)
Rectal  problems Family history of degenerative disease Sleep changes
Gastrointestinal problems Seizures, partial complex Restlessness
Problems cooking Seizures,  generalized Memory changes
Sucking problems Syncope  or blackouts Short-term memory impairment
Skin  problems Peripheral pulses Long-term memory impairment
Malignant  disease Cardiac problems Changes in general mental functioning
Breast problems Myocardial infarction Onset  of cognitive symptoms
Abdominal  problems Arrhythmia Clouding or delirium
Presence of snout reflex Congestive heart failure Paranoid features
Presence of the palmomental reflex Lung problems History relevant to cognitive impairment or loss
History of thyroid disease Respiratory problems Family history relevant to cognitive impairment or loss
Thyroid problems History of diabetes Headache
History of stroke Arterial hypertension Cerebrovascular problems
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fOther  medical history
ortality, unscheduled  return  visit,  and  in-hospital  and
ecurrent major  adverse  cardiovascular  events.23
Ekerstad  et  al.  used  frailty  as  measured  by  the  CFS  to
ssess short-term  outcomes  for  elderly  patients  with  non-ST-
egment elevation  myocardial  infarction,  and  showed  that
he combined  use  of  frailty  and  other  comorbidity  tools  (such
s the  coronary  artery  disease-specific  index)  may  constitute
 novel  risk  prediction  concept  in  regard  to  cardiovascular
atients with  complex  needs.24
Uchmanowicz  et  al.  investigated  the  correlation  of  a
cale for  assessing  frailty  --  the  Tilburg  Frailty  Indicator  and
ts mental  and  physical  domains  --  with  other  screening  tools
ommonly used  for  CGA  in  patients  with  ACS.  Significant  cor-
elations were  demonstrated  between  the  values  of  the  TFI
nd other  scales.50
Boxer  et  al.  also  found  that  the  six-minute  walk  and  the
ve-item Cardiovascular  Health  Study  were  independently
redictive of  mortality  in  older  adults  with  heart  failure,
ith hazard  ratio  (HR)  0.82  (95%  CI  0.72-0.94)  and  1.64  (95%
I 1.19-2.26),  respectively,  and  both  could  be  useful  as  a
easure of  frailty.17
In  a  prospective  observational  study  by  Jung  et  al.  in
lective cardiac  surgery  patients,  frailty  was  defined  using
he seven-item  Cardiovascular  Health  Study  score,  the  Short
hysical Performance  Battery  (SPPB)  and  a  35-item  frailty
ndex. They  found  that  the  addition  of  frailty  improved  the
bility of  the  EuroSCORE  II  to  predict  postoperative  delir-
um, pointing  to  opportunities  for  improved  prevention  and
anagement.29
The  CAF  is  a  tool  created  by  Sundermann  et  al.20 to  assess
he prognosis  of  elderly  patients  before  cardiac  surgical
nterventions and  accurately  predicts  mortality.  It  comprises
rip strength,  walking  speed,  balance,  and  ability  to  pick
p a  pen  from  the  floor,  rise  from  a  chair  three  times  and
ut on  and  remove  a  jacket,  thus  combining  characteristics
t
a
sf  the  CHS  criteria9 of  patient  phenotype,  physical  perfor-
ance, and  laboratory  results.  According  to  the  authors,
 combination  of  the  CAF  and  traditional  scoring  systems
ay facilitate  more  accurate  risk  scoring  in  elderly  high-
isk patients  scheduled  for  conventional  cardiac  surgery  or
ranscatheter aortic  valve  replacement.27 The  CAF  was  pre-
peratively applied  to  400  patients  aged  ≥74  years  admitted
o a  cardiac  surgical  department  between  September  2008
nd January  2010.  For  213  of  these  patients  one-year  follow-
p was  assessed  by  telephone  interview  until  April  2010.
ne hundred  and  ten  male  and  103  female  patients  were
ncluded. Twenty-five  percent  underwent  isolated  coronary
evascularization, 35%  isolated  valve  procedures  and  26%
nderwent combined  procedures.  One-year  mortality  was
2.2%. Patients  who  died  within  one  year  had  a  median
railty score  of  16  [5;33]  compared  to  11  [3;33]  in  one-
ear survivors  (p=0.001).20 Sundermann  et  al.  showed  that
he CAF  score  facilitates  prediction  of  mid-term  outcome  of
igh-risk elderly  patients  and  the  modified  CAF  score  showed
 promising  ability  to  predict  one-year  mortality  in  patients
ndergoing cardiac  surgery.20,27
The  study  by  Dunlay  et  al.  assessed  the  association
etween preoperative  frailty  and  worse  outcomes  after
mplantation of  an  LVAD.  Patients  undergoing  LVAD  implan-
ation as  destination  therapy  at  the  Mayo  Clinic,  Rochester,
N between  February  2007  and  June  2012  were  included
n this  study.  Frailty  was  assessed  using  a  deficit  index
including 31  impairments,  disabilities  and  comorbidities)
nd defined  as  the  proportion  of  deficits  present.  Patients
ere then  divided  based  on  tertiles  of  the  deficit  index
>0.32=frail, 0.23  to  0.32=intermediate  frail,  <0.23=not
rail). The  authors  concluded  that  frailty  before  destina-
ion LVAD  implantation,  as  assessed  by  their  deficit  index,  is
ssociated with  increased  risk  of  death  and  may  represent  a
ignificant patient  selection  consideration.30
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Some  tools  have  also  been  applied  to  patients  under-
going TAVI.  Stortecky  et  al.  assessed  the  Multidimensional
Geriatric Assessment  (MGA)  as  a  predictor  of  mortality
and MACCE  after  TAVI.  This  prospective  cohort  com-
prised 100  consecutive  patients  aged  ≥70  years  undergoing
TAVI. Global  risk  scores  (Society  of  Thoracic  Surgeons
[STS] score,  EuroSCORE)  and  MGA-based  scores  (cogni-
tion, nutrition,  mobility,  activities  of  daily  living  [ADL],
and frailty  index)  were  assessed  as  predictors  of  all-cause
mortality and  MACCE  30  days  and  one  year  after  TAVI.
This study  provides  evidence  that  risk  prediction  can  be
d
e
u
l
Table  4  Tools  used  to  assess  frailty  in  cardiovascular  disease.
Study  Tool  Measurement  method  
Sundermann
et  al.20
CAF  •  Patient  is  asked  to  get  u
chair  3  times  and  time  is  
• Self-reported  weakness
• Patient  is  asked  to  climb
they  are  able
• Two  physicians  (one  a  ca
conduct  the  CFS  from  the
Serum  creatinine  level
Green  et  al.53 Modified  Fried
frailty criteria
•  Slow  15-m  gait  speed
• Weak  dominant  handgri
•  Assistance  required  in  a
of  Independence  in  Activi
criteria
•  Serum  albumin  as  a  mea
of malnutrition
Afilalo et  al.28 4  scales  used:
• 5-item  Modified
Fried Criteria
• 7-item  expanded
Modified  Fried
Criteria
• 4-item  MSSA
• Five-Meter  Gait
Speed Test
•  5-item  Modified  Fried  Cr
handgrip  strength,  inactiv
and  weight  loss
• 7-item  Modified  Fried  Cr
well  as  cognitive  impairm
mood
•  4-item  MSSA  used  gait  s
strength,  inactivity,  and  c
•  prolonged  time  for  gait  
to  walk  5  m)
Stortecky  et  al.31 Multidimensional
Geriatric
Assessment
• MMSE  showing  cognitive
MNA  shows  malnutrition
• TUG  showing  limitation  
• BADL  and  instrumental  a
living  showed  an  activity  
•  Preclinical  mobility  disa
decreased  frequency  of  w
and/or  climbing  stairs  in  p
Schoenenberger
et  al.26
Geriatric  baseline
examination
• MMSE  showing  cognitive
•  MNA  shows  malnutrition
• TUG  showing  limitation  
• BADL  and  instrumental  a
living  showed  an  activity  
•  Preclinical  mobility  disa
decreased  frequency  of  w
and/or  climbing  stairs  in  p151
mproved  by  adding  MGA-based  information  to  global  risk
cores.31
Schoenenberger  et  al.  used  the  EuroSCORE,  the  STS
core, and  a geriatric  baseline  examination  (based  on
ssessment of  cognition,  mobility,  nutrition,  instrumental
nd basic  activities  of  daily  living)  to  predict  functional
ecline in  elderly  patients  undergoing  TAVI.  Overall  pre-
ictive performance  was  best  for  the  geriatric  baseline
xamination and  low  for  the  EuroSCORE  and  STS  score.  In
nivariate analysis,  all  components  of  the  geriatric  base-
ine examination  helped  predict  functional  decline.  The
Criteria  for  frailty
p  and  down  from  a
measured
 as  many  stairs  as
rdiac  surgeon)
 CSHA
Results  from  the  CAF  scores  are
tabulated  into  a  scale  from  1
to  35  points  as  outlined  by  the
supplementary  CAF  Test  Sheet.  Scores
between  1  and  10  are  deemed  not
frail,  between  11  and  25  are  deemed
moderately  frail,  and  between  26
and  36  are  deemed  severely  frail
p  strength
ny  of  Katz  Index
ties  of  Daily  Living
surement
Frailty  defined  as  a  score  >5  on  a
scale  from  0-12  where  a  higher  score
equates  to  more  frail
For gait  speed,  grip  strength,  and
serum  albumin,  based  on  which
quartile  a  patient  was  in,  a  value  of
0-3  was  given  for  each  quartile  in
descending  order.  For  activities  of
daily  living,  0  points  were  given  for
independent  and  3
for dependent
iteria:  gait  speed,
ity,  exhaustion,
iteria:  the  above  as
ent  and  depressed
peed,  handgrip
ognitive  impairment
speed  test  (>6  s
Defined  as  frail  if  any  of  the  4  scales
deemed  patient  as  frail
 impairment
of  mobility
ctivities  of  daily
with  limitation
bility  defined  as
alking  200  m
receding  6  months
Defined frailty  as  ≥3  points,  2  points
if  MMSE  <21,  1  point  if  MMSE  ≥21  and
<27,  MNA  <12,  TUG  ≥20  s,  BADL  with
at  least  1  limited  activity,
instrumental activities  of  daily  living
with  at  least  1  limited  activity,
preclinical mobility  disability
 impairment
of  mobility
ctivities  of  daily
with  limitation
bility  defined  as
alking  200  m
receding  6  months
Defined frailty  as  ≥3  points,  2  points
if  MMSE  <21,  1  point  if  MMSE  ≥21,
and  <27,  MNA  <12,  TUG  ≥20  s,  BADL
with  at  least  1  limited  activity,
instrumental activities  of  daily  living
with  at  least  1  limited  activity,
preclinical mobility  disability
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Table  4  (Continued)
Study  Tool  Measurement  method  Criteria  for  frailty
Jung  et  al.29 Modified  Fried
Frailty Criteria
definition  of  frailty
Slowness
-- After  two  trials  of  a  5  m  walk,  average  time  >6  s
Weakness
--  After  three  grip  strength  measurements  with  each
hand,  maximum  value  ≤30  kg  if  male  or  ≤20  kg  if  female
Weight  loss
-- Self-reported  weight  loss  >4.5  kg  (10  lbs)  or  >5%  body
weight  in  past  12  months
Exhaustion
-- Two-item  CES-D  scale  ≥1  out  of  2
Depression
--  5-GDS  ≥2  out  of  5
Low physical  activity
-- Paffenbarger  Physical  Activity  Index  <383  kcal
per  week  if  male  or  <270  kcal  per  week  if  female
Cognitive  impairment
-- MoCA  score  <26  out  of  30
Patient was  deemed  frail  if  at
least  3  of  the  7  criteria  were
present
35-item Frailty
Index
(i)  Comorbidities
--  Angina
--  Arthritis
--  Asthma
--  Cerebrovascular  disease
-- Cognitive  impairment
-- COPD
--  Dyslipidemia
--  Gastrointestinal  disease
-- Hearing  impairment
-- Hypertension
--  Myocardial  infarction
-- Pacemaker
-- Peripheral vascular  disease
-- Pre-operative atrial  flutter  or  fibrillation
-- Prior  angioplasty  or  stent
-- Pulmonary hypertension
-- Solid tumor
-- Visual  impairment
(ii) Physical  and  emotional  measures
--  Decline  in  food  intake
-- Depression  based  on  the  5-GDS
-- Exhaustion  based  on  the  two-item  CES-D
--  Falls  in  past  year
-- Inability  to  complete  repeated  chair  stand  test
--  Low  physical  activity  based  on  Paffenbarger  Physical
Activity  Index
-- Poor  balance
-- Self-rating  of  health
-- TUG
--  Unintentional  weight  loss  in  past  3  months
--  Unintentional  weight  loss  >4.5  kg  (10  lbs)
--  Weak  grip
(iii) Functional  measures
-- Banking,  inability  to  perform
-- Cleaning,  inability  to  perform
-- Cooking,  inability  to  perform
-- Driving,  inability  to  perform
Frailty Index  score=individual’s
total number  of  deficits/35
Deficits: each  counted  as
present or  absent-- Shopping,  inability  to  perform
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Table  4  (Continued)
Study  Tool  Measurement  method  Criteria  for  frailty
SPPB  (i)  5-m  gait  speed  measurement
-- After  two  trials,  average  time:
≤6.5 s:  4  points;  6.6-8.3  s:
3 points;  8.4-11.6  s:  2  points;
≥11.7 s:  1  point;  unable:  0  points
(ii)  Balance  tests
-- Side-by-side  stand  time
≥10 s:  1  point;  <10  s:  0  points;
-- Semi-tandem  stand
≥10 s:  1  point;  <10  s:  0  points
-- Tandem  stand
≥10 s:  2  points;  3-9.99  s:  1  point;
<3 s:  0  points
(iii) Repeated  chair  stand  test
--  Time  to  stand  up  from  chair
5 times
≤11.19  s:  4  points;  11.20-13.69  s:
3  points;  13.70-16.69  s:  2  points;
16.70-59.99 s:  1  point;  ≥60  s
or  unable:  0  points
Patient  was  deemed  frail  if
composite score  ≥9  points
Uchmanowicz
et  al.50
TFI  First  part:
Sociodemographic  characteristics
of a  participant:
gender,  age,  marital  status,
country of  origin,  educational
level, and  monthly  income
Potential determinants  of  frailty.
Second  part:
Components  of  frailty  (15
self-reported questions,  divided
into  three  domains):
- Physical  domain  (0-8  points):
eight questions  related  to  physical
health,  unexplained  weight  loss,
difficulty in  walking,  balance
problems, hearing  problems,
vision problems,  strength  in
hands,  and  physical  tiredness.
- Psychological  domain  (0-4
points): four  items  related  to
cognition,  depressive  symptoms,
anxiety, and  coping.
- Social  domain  (0-3  points):  three
questions related  to  living  alone,
social  relations,  and  social
support.
Eleven items  from  part  two  of  the  TFI
have  two  response  categories  (‘‘yes’’
and  ‘‘no’’),  while  the  other  items
have three  (‘‘yes’’,  ‘‘no,’’
and ‘‘sometimes’’).
‘‘Yes’’  or  ‘‘sometimes’’  responses
are  scored  1  point  each,  while  ‘‘no’’
responses  are  scored  0.
The instrument’s  total  score  may
range from  0  to  15:  the  higher  the
score,  the  higher  one’s  frailty.
Frailty is  diagnosed  when  the  total
TFI  score  is  >5.
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Table  4  (Continued)
Study  Tool  Measurement  method  Criteria  for  frailty
Dunlay  et  al.30 31-item  deficit
index
Need help  preparing  meals
Need help  feeding  yourself
Need help  dressing  yourself
Need help  using  the  toilet
Need help  with  housekeeping
Need help  climbing  stairs
Need help  bathing
Need help  walking
Need help  using  transportation
Need help  getting  in  and  out  of  bed
Need  help  managing  medications
Depend on  assistive  devices  (walker,  cane,
etc.)  or  other  people  to  perform  activities
of  daily  life
Dependent  on  a  device  for  normal  breathing
Climb  2  flights  of  stairs  without  rest
Myocardial  infarction
Diabetes
Peripheral vascular  disease
Cerebrovascular disease
COPD
Ulcer
Hemiplegia
Moderate/severe  renal  insufficiency
History of  liver  disease
Rheumatologic  disease
History of  malignancy
History of  dementia
Hypertension
Hyperlipidemia
Body mass  index
Depression
Anemia
Yes=1,  No=0
Yes=1, No=0
Yes=1, No=0
Yes=1, No=0
Yes=1, No=0
Yes=1, No=0
Yes=1, No=0
Yes=1, No=0
Yes=1, No=0
Yes=1, No=0
Yes=1, No=0
Yes=1, No=0
Yes=1, No=0
No, cannot  do  at  all=1;  Yes,  with
difficulty=0.5;  Yes  with  no  difficulty=0
Yes=1,  No=0
Yes=1,  No=0
Yes=1, No=0
Yes=1, No=0
Yes=1, No=0
Yes=1, No=0
Yes=1, No=0
Yes=1, No=0
Yes=1, No=0
Yes=1, No=0
Yes=1, No=0
Yes=1, No=0
Yes=1, No=0
Yes=1, No=0
Underweight  or  obese=1;
overweight=0.5;  normal=0
Yes=1, No=0
Yes=1, No=0
Yes=1, No=0
Yes=1, No=0
Patients  were  divided  into  tertiles
of the  deficit  index:
Lowest tertile=not  frail;  middle
tertile=intermediate frail;  highest
tertile=frail
Afilalo  et  al.51 Essential  Frailty
Toolset
(i) Time  to  stand  5  times  from  a  seated
position  without  using  arms:  <15  s=0  points;
≥15  s=1  point;  unable  to  complete=2  points
(ii)  Cognition:  MMSE  ≥24:  0  points;  MMSE  <24:
1  point
(iii)  Hemoglobin:  ≥13  g/dl  (in  men)
or  ≥12  g/dl  (in  women):  0  points;  <13  g/dl  (in
men)
or  <12  g/dl  (in  women):  1  point
(iv) Serum  albumin:
≥3.5 g/dl:  0  points;  <3.5  g/dl:  1  point
Composite  score:  0-5
5-GDS: five-item Geriatric Depression Scale; BADL: basic activities of daily living; CAF: Comprehensive Assessment of Frailty score;
CES-D: Center for Epidemiologic Studies Depression scale; CFS: Clinical Frailty Scale; COPD: chronic obstructive pulmonary disease;
CSHA: Canadian Study of Health and Aging; MMSE: Mini Mental State Exam; MNA: Mini Nutritional Assessment; MoCA: Montreal Cognitive
Assessment score; MSSA: 4-item MacArthur Study of Successful Aging frailty scale; SPPB: Short Physical Performance Battery; TFI: Tilburg
Frailty Indicator; TUG: Timed Up and Go test.
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Table  5  Comparison  of  the  frailty  phenotype  and  frailty
indices.57
Frailty  phenotype  Frailty  indices
Performance  on
five variables
Deficit  count  or  proportion  of
potential deficits  that  a  person  has
accumulated
Signs,  symptoms  Diseases,  activities  of  daily  living,
results  of  a  clinical  evaluation
Possible  before  a
clinical
assessment
Doable  only  after  a  comprehensive
clinical assessment
Categorical
variable
Continuous  variable
Predefined  set
of criteria
Unspecified  set  of  criteria
Frailty  as  a
pre-disability
syndrome
Frailty  as  an  accumulation  of  deficits
Meaningful  results
potentially
restricted to
non-disabled  older
persons
Meaningful  results  in  every
individual, independently
of functional  status  or  age
Advantages:
-  performance-
based
-  easy  to  apply
Advantages:
-  simple  approach
- robust  indicator  of  frailty
Disadvantages:
-  floor  effect  for
some variables
(immobile
patients)
Disadvantages:
-  cumbersome  in  clinical  setting
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authors  concluded  that  the  geriatric  baseline  examination,
but not  established  risk  scores,  was  predictive  of  functional
decline.26
In  the  2012  study  by  Afilalo  et  al.,  a  total  of  152  patients
were enrolled  in  a  prospective,  multicenter  cohort  study  of
elderly patients  (>70  years)  undergoing  CABG  and/or  valve
surgery in  the  US  and  Canada.  Four  different  frailty  scales,
three disability  scales,  and  five  cardiac  surgery  risk  scores
were measured  in  all  patients.  The  primary  outcome  was  the
STS composite  endpoint  of  in-hospital  postoperative  mortal-
ity or  major  morbidity.  The  four  frailty  scales  examined  in
this study  are  described  in  Table  4.  The  authors  concluded
that clinicians  should  use  an  integrative  approach  combin-
ing frailty,  disability,  and  risk  scores  to  better  characterize
elderly patients  referred  for  cardiac  surgery  and  identify
those that  are  at  increased  risk.28
The  same  author,  in  a  recent  study  (2017),51 compared
the incremental  predictive  value  of  seven  different  frailty
scales to  predict  poor  outcomes  following  TAVI  and  valve
surgery: the  Fried  criteria  (described  above),9 Fried+(the
Fried criteria  plus  cognition  assessed  by  the  Mini  Mental
State Exam  [MMSE]  and  mood  assessed  by  the  Short-form
Geriatric Depression  Scale),  the  Rockwood  CFS,39 the  SPPB
(three physical  tests,  with  each  scored  0  to  4  for  a  composite
score of  0  to  12:  gait  speed,  time  to  stand  five  times  from  a
seated position  without  using  arms  and  the  ability  to  stand
10 s with  the  feet  in  tandem  or  side-by-side  positions),52
the  Bern  Scale  (six  items  for  a  composite  score  of  0  to  7:
gait speed,  mobility,  cognition,  nutrition  and  disability  in
activities of  daily  living  and  instrumental  activities),26,31 the
Columbia Scale  (four  items,  with  each  scored  0  to  3  for  a
composite score  of  0  to  12:  gait  speed,  grip  strength,  serum
albumin and  disability),53 and  the  Essential  Frailty  Toolset
(EFT) (four  items  for  a  composite  score  of  0  to  5:  time
to stand  five  times  from  a  seated  position  without  using
arms (1  point  if  ≥15  s,  2  points  if  unable  to  complete),
cognition (1  point  if  MMSE  <24),  hemoglobin  (1  point  if  <13
g/dl in  men  or  <12  g/dl  in  women),  and  serum  albumin  (1
point if  <3.5  g/dl).51 Frailty  as  measured  by  the  EFT  was  the
strongest predictor  of  death  at  one  year  (p<0.001)  and  of
worsening disability  at  1  year  (adjusted  OR:2.13;  95%  CI:1.57
to 2.87)  and  death  at  30  days  (adjusted  OR:  3.29;  95%  CI:
1.73 to  6.26).
Some authors,  instead  of  validating  existing  frailty
screening tools,  used  certain  parameters  to  derive  their
own frailty  score.  Green  et  al.  used  a  modification  of  the
Fried frailty  criteria  that  included  gait  speed,  grip  strength,
serum albumin,  and  activities  of  daily  living  status  to  derive
a frailty  score  among  older  adults  with  severe  aortic  stenosis
who underwent  TAVI.  In  this  study  frailty  was  not  associated
with increased  periprocedural  complications  in  patients
selected as  candidates  to  undergo  TAVR,  but  was  associated
with increased  one-year  mortality  after  TAVR.53
Screening  tools:  critical  analysis
We  have  described  individual  multiple  frailty  measurement
scales. There  have  been  various  studies  comparing  the  most
commonly  used  screening  tools,  but  agreement  on  which  has
the  best  ability  to  predict  prognosis  and  all-cause  mortality
is lacking.  While  some  studies  found  similar  prognostic
m
a
u
berformance  in  some  of  these  tools,54,55 other  studies  found
ignificant differences.56 In  2013,  a  consensus  conference
dentified some  of  these  tools  as  allowing  physicians  to
bjectively recognize  frail  persons.6 However,  they  range
rom short,  fast  and  crude  screening  tools  to  sophisticated
nd time-consuming  scales.  A  source  of  concern  is  the  fact
hat many  frailty  scales  have  been  modified  somewhat  from
heir original  and  validated  version,  leading  to  significant
ifferences in  frailty  classification.33
Since  the  frailty  phenotype  and  frailty  indices  are  based
n different  concepts,  it  is  inappropriate  to  consider  them
s alternatives  and/or  interchangeable.57 Table  5  describes
he main  characteristics  of  these  two  different  instruments.
The  FRAIL  screening  tool  is  clinically  advantageous  due
o its  simple  nature  and  ability  to  be  obtained  from  data
lready included  in  a  CGA.2 It  has  been  found  to  be  pre-
ictive of  mortality  in  specific  populations,  such  as  patients
ith CVD.43
The  CHS  scale  (Fried  criteria)  is  a  widely  used  scale
pplied in  multiple  epidemiological  studies,  and  has  good
redictive value  for  adverse  clinical  outcomes,  including
ortality. However,  a  major  factor  precluding  its  clinical
pplication is  the  inclusion  of  measurements  not  routinely
sed for  patient  assessment  (such  as  grip  strength  measured
y a  dynamometer).  Another  important  limitation  of  this
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R56  
cale  is  that  it  does  not  include  psychosocial  components
f frailty.9
The  CFS  has  been  validated  as  a  predictor  of  adverse
utcomes in  hospitalized  older  people,  such  as  all-cause,
n-hospital mortality,  one-month  mortality  and  prolonged
ospital care.23,24,33
Deficit  accumulation-based  frailty  indices  are  well  vali-
ated and  are  better  at  predicting  adverse  clinical  events
han other  frailty  measurements  in  both  hospital  and
ommunity settings.  They  have  been  applied  to  multiple
atasets, but  can  be  time-consuming  to  calculate.  The  FI-
GA is  used  as  a  clinical  standard  for  frailty  assessment  and
as been  found  to  predict  patient  response  in  multiple  fields,
ncluding cardiology.2
The  EFS  is  a  valid  and  reliable  measurement  tool  in  the
ospital setting  and,  since  it  has  only  nine  components,  it
s much  simpler  to  extract  from  CGAs  than  the  FI-CGA.42
n  a  community-based  sample,  even  when  administered  by
on-specialists with  no  formal  training  in  geriatric  care,
he EFS  compared  favorably  with  the  clinical  assessment  of
eriatric specialists  who  completed  a  more  comprehensive
valuation.42
Compared  with  other  frailty  assessment  tools,  the  MPI
ppears to  have  greater  ability  to  predict  adverse  outcomes.
evertheless, additional  research  is  needed  to  confirm  these
esults.33,49
The  GFI  has  moderate  internal  consistency  and  adequate
iscriminative ability,  and  shows  good  feasibility  and  relia-
ility as  a  frailty  measurement.  Some  authors  have  proposed
hat it  should  be  used  together  with  a  frailty  index  as  part
f a  two-step  screening  process.58
The  TFI  shows  good  reliability  for  identifying  frailty
n community-dwelling  older  people.  However,  although
ts physical  components  show  good  ability  to  predict
dverse events,  its  social  components  appear  to  be  weak
redictors.59,60
The  GFST,  designed  for  early  recognition  of  frailty  in
ommunity-dwelling older  people,  appears  to  be  a good
railty screening  tool;  however,  it  gives  no  specific  guidance
or clinicians  on  how  to  identify  frailty  and  the  clinician’s
udgment of  frailty  status  is  quite  subjective.33
Although  PRISMA-7  shows  good  accuracy  in  identifying
railty in  community-dwelling  older  people,  its  ability  as  a
creening tool  is  limited  since  it  has  a  tendency  to  over-
creen for  frailty.59
Some  of  these  tools  have  also  been  used  in  cardiovascular
atients, such  as  the  Fried  frailty  criteria,17,23,24,29 frailty
ndices,29,30 and  the  TFI.50
The  geriatric  baseline  examination  developed  by  Schoe-
enberger et  al.,26 the  multidimensional  geriatric  assess-
ent used  by  Stortecky  et  al.,31 and  the  CAF,20,27 developed
y Sundermann  et  al.,  are  three  recent  frailty  tools  which
ave been  shown  to  be  useful  in  predicting  mortality  and
ssessing prognosis  of  elderly  patients  with  CVD  or  before
ardiac surgical  interventions.
Some authors,  such  as  Afilalo  et  al.,  prefer  to  use  an  inte-
rative approach  combining  frailty,  disability,  and  risk  scores
o better  characterize  elderly  patients  referred  for  cardiac
urgery, which  has  proved  to  be  useful  for  identifying  those
t increased  risk.28
The  same  author  recently  showed  the  superiority  of  the
FT compared  to  other  frailty  scales  when  predicting  poorA.  Zão  et  al.
utcomes  following  TAVI  and  valve  surgery,  since  it  is  a  rel-
tively simple  tool  that  is  neither  particularly  burdensome
or time-consuming  and  at  the  same  time  captures  multiple
omains of  frailty.  The  authors  suggested  it  had  the  highest
redictive value  for  death  and  worsening  disability  at  one
ear and  recommended  its  use  in  this  setting.51
Assessment  of  frailty  as  a  preoperative  surgical  risk  factor
as been  shown  to  be  useful  and  may  increase  the  number
f elderly  patients  considered  eligible  for  surgical  interven-
ions, since  it  enables  prior  screening  for  risk  and  prediction
f surgical  success  and  safety.
When  selecting  a  screening  tool,  it  is  also  important
o take  into  account  the  ecology  of  its  application,  since
ome frailty  measurements  are  more  suitable  for  use  in
opulation health  studies  as  screening,  whereas  others  are
ppropriate in  the  clinical  setting  for  screening  or  diagnosis
f frailty.42,55,57
onclusion
railty  is  an  important  prognostic  factor  in  patients  with
VD. It  increases  the  risk  of  adverse  events  associated
ith cardiovascular  therapeutic  interventions,  and  there-
ore needs  to  be  taken  into  account  when  considering
hether to  intervene.  Frail  patients  may  have  more
omplications and  fewer  benefits  because  of  the  competing
dverse event  risk.  The  clinical  relevance  of  frailty  assess-
ent will  be  even  greater  in  the  future  because  the  number
f frail  patients  with  CVD  is  set  to  grow  as  populations
ge. Both  successful  treatment  approaches  for  frail  patients
nd the  inclusion  of  frailty  when  assessing  patients  for  CVD
ntervention require  the  systematic  and  routine  identifica-
ion of  frailty.  Simple  and  rapid  screening  tests  have  been
eveloped and  validated  to  enable  the  objective  recognition
f frail  persons.  There  are  significant  differences  between
hese scales  in  their  nature,  validity  and  feasibility.  Further
tudies are  needed  to  establish  their  significance  regarding
verall and  cardiovascular  mortality.  In  the  CVD  field,  the
wo most  commonly  used  and  most  robust  frailty  assessment
ools for  use  by  clinicians  and  researchers  are  the  Fried  crite-
ia and  frailty  indices.  Other  new  tools  specifically  designed
or CVD  have  proved  extremely  useful  for  this  propose.  In
ine with  previous  studies,  we  suggest  the  use  of  one  simple
ool for  frailty  screening  and  a  second  one  for  a full  assess-
ent, and  for  these  purposes  we  recommend  the  use  of  the
ried criteria  and  a  frailty  index,  respectively.  The  impact  of
herapeutic strategies  targeting  frailty  itself  is  still  unclear.
evertheless, routine  screening  and  objective  diagnosis  of
railty is  bound  to  improve  the  therapeutic  decision-making
rocess and  prognostic  assessment  of  patients  with  CVD.
onflicts of  interest
he  authors  have  no  conflicts  of  interest  to  declare.
eferences1. Heart disease and stroke: the nation’s leading killers; 2005
http://www.cdc.gov
2. Singh M, Stewart R, White H. Importance of frailty in patients
with cardiovascular disease. Eur Heart J. 2014;35:1726-31.
22
2
2
2
3
3
3
3
3
3
3
3
3
3
4
4
4
4
4Frailty  in  cardiovascular  disease  
3. Strandberg T, Pitkala K. Frailty in elderly people. Lancet.
2007;369:1328--9.
4. Rodríguez-Man˜as L, Féart C, Mann G, et al. Searching for
an operational definition of frailty: a delphi method based
consensus statement. Frailty Oper Def Cons Conf Project.
2013;68:62--7.
5. Clegg A, Young J, Iliffe S, et al. Frailty in older people. Lancet.
2014;381:752--62.
6. Morley J, Vellas B, Van Kan A, et al. Frailty Consensus: a call to
action. 2014;14:392--7.
7. Ferrucci L, Cavazzini C, Corsi A, et al. Biomarkers of frailty in
older persons. J Endocrinol Invest. 2002;25 Suppl.:10--5.
8.  Collard R, Boter H, Schoevers R, et al. Prevalence of frailty in
community-dwelling older persons: a systematic review. J Am
Geriatr Soc. 2012;60:1487--92.
9. Fried L, Tangen C, Walston J, Cardiovascular Health Study Col-
laborative Research Group. Frailty in older adults: evidence for
a phenotype. J Gerontol A Biol Sci Med Sci. 2001;56:M146--56.
10.  Walston J, McBurnie M, Newman A, et al. Frailty and activation
of the inflammation and coagulation systems with and without
clinical comorbidities: results from the Cardiovascular Health
Study. Arch Intern Med. 2002;162:2333--41.
11. Chaves P, Semba R, Lenga S, et al. Impact of anemia and cardio-
vascular disease on frailty status of community-dwelling older
women: the women’s health and aging studies I and II. J Geron-
tol A Biol Sci Med Sci. 2005;60:729--35.
12. Cappola A, Xue Q, Fried L. Multiple hormonal deficiencies
in  anabolic hormones are found in frail older women: the
Women’s Health and Aging studies. J Gerontol A Biol Sci Med
Sci. 2009;64:243--8.
13. Varadhan R, Chaves P, Lipsitz L, et al. Frailty and impaired
cardiac autonomic control: new insights from principal compo-
nents aggregation of traditional heart rate variability indices.
J Gerontol A Biol Sci Med Sci. 2009;64:682--7.
14.  Barzilay J, Blaum C, Moore T, et al. Insulin resistance and inflam-
mation as precursors of frailty: the Cardiovascular Health Study.
Arch Intern Med. 2007;167:635--41.
15. Yao X, Li H, Leng S. Inflammation and immune system alterations
in frailty. Clin Geriatr Med. 2011;27:79--87.
16.  Semba R, Ferrucci L, Sun K, et al. Oxidative stress and
severe  walking disability among older women. Am J Med.
2007;120:1084--9.
17. Boxer R, Kleppinger A, Ahmad A, et al. The 6-minute walk is
associated with frailty and predicts mortality in older adults
with heart failure. 2011;16:208--13.
18. Sanchez E, Vidan M, Serra J, et al. Prevalence of geriatric syn-
dromes and impact on clinical and functional outcomes in older
patients with acute cardiac diseases. Heart. 2011;97:1602--6.
19. Lee D, Buth K, Martin B, et al. Frail patients are at increased
risk for mortality and prolonged institutional care after cardiac
surgery. Circulation. 2010;121:973--8.
20. Sundermann S, Dademasch A, Rastan A, et al. One-year follow-
up of patients undergoing elective cardiac surgery assessed with
the Comprehensive Assessment of Frailty test and its simplified
form. Interact Cardiovasc Thorac Surg. 2011;13:119--23.
21.  Roe M, Armstrong P, Fox K, et al. Prasugrel versus clopidogrel
for  acute coronary syndromes without revascularization. N Engl
J Med. 2012;367:1297--309.
22. Volpato S, Cavalieri M, Sioulis F, et al. Predictive value of the
Short Physical Performance Battery following hospitalization in
older patients. J Gerontol A Biol Sci Med Sci. 2011;66:89--96.
23.  Kang L, Zhang S-Y, Zhu W-L, et al. Is frailty associated with
short-term outcomes for elderly patients with acute coronary
syndrome? J Geriatr Cardiol. 2015;12:662--7.
24.  Ekerstad N, Swahn E, Janzon M, et al. Frailty is independently
associated  with short-term outcomes for elderly patients with
4157
non-ST-segment elevation myocardial infarction. Circulation.
2011;124:2397--404.
5. Ricci NA, Pessoa GS, Ferriolli E, et al. Frailty and cardiovascular
risk  in community-dwelling elderly: a population-based study.
Clin Interv Aging. 2014;9:1677--85.
6. Schoenenberger A, Stortecky S, Neumann S, et al. Predictors
of functional decline in elderly patients undergoing tran-
scatheter aortic valve implantation (TAVI). Eur Hear J. 2013;34:
684--92.
7. Sündermann S, Dademasch A, Praetorius J, et al. Compre-
hensive assessment of frailty for elderly high-risk patients
undergoing cardiac surgery. Eur J Cardiothorac Surg. 2011;39:
33--7.
8. Afilalo J, Mottillo S, Eisenberg MJ, et al. Addition of frailty
and  disability to cardiac surgery risk scores identifies elderly
patients at high risk of mortality or major morbidity. Circ Car-
diovasc Qual Outcomes. 2012;5:222--8.
9. Jung P, Pereira MA, Hiebert B, et al. The impact of frailty on
postoperative delirium in cardiac surgery patients. J Thorac
Cardiovasc Surg. 2015;149:869--75.e2.
0. Dunlay SM, Park SJ, Joyce LD, et al. Frailty and outcomes after
implantation of left ventricular assist device as destination
therapy.  J Hear Lung Transplant. 2014;33:359--65.
1.  Stortecky S, Schoenenberger AW,  Moser A, et al. Evalua-
tion of multidimensional geriatric assessment as a predictor
of mortality and cardiovascular events after transcatheter
aortic  valve implantation. JACC Cardiovasc Interv. 2012;5:
489--96.
2. Furukawa H, Tanemoto K. Frailty in cardiothoracic surgery: sys-
tematic review of the literature. Gen Thorac Cardiovasc Surg.
2015;63:425--33.
3. Dent E, Hoogendijk PKE. Frailty measurement in research and
clinical practice: a review. Eur J Intern Med. 2016:S0953.
4.  Walston JD, Bandeen-roche K. Frailty: a tale of two concepts.
BMC  Med. 2015;13:185.
5. Lopez D, Flicker L, Dobson A. Validation of the
frail  scale in a cohort of older Australian women.
J  Am Geriatr Soc. 2012;60:171--3.
6. Morley J, Malmstrom T, Miller D. A simple frailty questionnaire
(FRAIL) predicts outcomes in middle aged African Americans. J
Nutr Heal Aging. 2012;16:601--8.
7. Woo  J, Leung J, Morley J. Comparison of frailty indica-
tors  based on clinical phenotype and the multiple deficit
approach in predicting mortality and physical limitation.
J  Am Geriatr Soc. 2012;60:1478--86.
8. Woo  J, Yu R, Wong M, et al. Frailty screening in the community
using the FRAIL scale. J Am Med Dir Assoc. 2015;16:412.
9.  Rockwood K, Song X, Macknight C, et al. A global clini-
cal  measure of fitness and frailty in elderly people. CMAJ.
2005;173:489--95.
0. Rockwood K, Mitnitski A. Frailty defined by deficit accumula-
tion and geriatric medicine defined by frailty. Clin Geriatr Med.
2011;27:17--26.
1.  Mitnitski A, Mogilner A, Rockwood K, et al. Accumulation of
deficits as a proxy measure of aging. ScientificWorldJournal.
2001;1:323--36.
2.  Rolfson D, Majumdar S, Tsuyuki R, et al. Validity and reliability
of the Edmonton Frail Scale. Age Ageing. 2006;35:526--9.
3.  Bandeen-Roche K, Xue Q, Ferrucci L, et al. Phenotype of frailty:
characterization in the women’s health and aging studies.
J  Gerontol A Biol Sci Med Sci. 2006;61:262--6.
4.  Rockwood K, Mitnitski A. Frailty in relation to the accumulation
of deficits. J Gerontol A Biol Sci Med Sci. 2007;62:722.5.  Schuurmans H, Steverink N, Lindenberg S, et al. Old or
frail: what tells us more? J Gerontol A Biol Sci Med Sci.
2004;59A:M962--5.
14
4
4
4
5
5
5
5
5
5
5
5
5
558  
6. Gobbens R, van Assen M, Luijkx K, et al. The Tilburg frailty
indicator:  psychometric properties. J Am Med Dir Assoc.
2010;11:344--55.
7. Subra J, Gillette-Guyonnet S, Cesari M. The integration of frailty
into clinical practice: preliminary results from the Gérontopôle.
J Nutr Heal Aging. 2012;16:714--20.
8. Raiche M, Hebert R, Dubois M. PRISMA-7: a case-finding tool to
identify older adults with moderate to severe disabilities. Arch
Gerontol Geriatr. 2008;47:9--18.
9. Pilotto A, Ferrucci L, Franceschi M, et al. Development and
validation of a multidimensional prognostic index for one-year
mortality from comprehensive geriatric assessment in hospital-
ized older patients. 2009;11:151--61.
0. Uchmanowicz I, Lisiak M, Wontor R, et al. Frailty in patients
with acute coronary syndrome: comparison between tools for
comprehensive geriatric assessment and the Tilburg Frailty Indi-
cator. Clin Interv Aging. 2015;10:521--9.
1. Afilalo J, Lauck S, Kim D, et al. Frailty in older adults undergoing
aortic valve replacement -- the FRAILTY-AVR study. J Am Coll
Cardiol. 2017;70:689--700.
2. Guralnik J, Simonsick E, Ferrucci L. Al. E. A short physical
performance battery assessing lower extremity function: asso-
ciation with self-reported disability and prediction of mortality
and nursing home admission. J Gerontol. 1994;49:M85--94.
3.  Green P, Woglom AE, Genereux P, et al. The impact of frailty
status on survival after transcatheter aortic valve replacement
6A.  Zão  et  al.
in older adults with severe aortic stenosis: a single-center expe-
rience. JACC Cardiovasc Interv. 2012;5:974--81.
4.  Kiely D, Cupples L, Lipsitz L, et al. Validation and comparison
of  two frailty indexes: the MOBILIZE Boston Study. J Am Geriatr
Soc. 2009;57:1532--9.
5. Ensrud K, Ewing S, Taylor B, et al. Comparison of 2 frailty
indexes  for prediction of falls, disability, fractures, and death
in older women. Arch Intern Med. 2008;168:382.
6.  Theou O, Brothers TD, Mitnitski A, et al. Operationalization of
frailty using eight commonly used scales and comparison of their
ability to predict all-cause mortality. 2013;61:1537--51.
7.  Cesari M, Gambassi G, van Kan G, et al. The frailty pheno-
type and the frailty index: different instruments for different
purposes.  Age Ageing. 2014;43:10--2.
8. Drubbel I, Bleijenberg N, Kranenburg G, et al. Identifying
frailty:  do the Frailty Index and Groningen Frailty Indicator
cover different clinical perspectives? A cross-sectional study.
BMC Fam Pr. 2013;14:64--9.
9. Clegg A, Rogers L, Young J. Diagnostic test accuracy of sim-
ple instruments for identifying frailty in community-dwelling
older  people: a systematic review. 2015, http://dx.doi.org/10.
1093/ageing/afu157.0.  Karapolat H, Eyigor S, Zoghi M, et al. Are swimming or aer-
obic exercise better than conventional exercise in ankylosing
spondylitis patients? A randomized controlled study. Eur J Phys
Rehabil Med. 2009;45:449--57.
